Newsroom of cameras and stage lighting.

Leading transformation in clinical development

It’s about time for clinical research solutions that bring treatments to patients faster, with new technologies that accelerate trials

Explore how to harness this transformational moment in clinical development from experts at the PPD™ clinical research business of Thermo Fisher Scientific.

Integrated, end-to-end clinical development solutions

Sponsors looking to gain speed, simplicity and scalability should look no further than our integrated CRO and CDMO capabilities to streamline the drug development process and enhance better outcomes.

Integrated solutions to accelerate and economize clinical trial development

36 seconds

Expert info

Mike Kleppinger, president, commercial, PPD clinical research business of Thermo Fisher Scientific

Collaboration and communication to mitigate risks and accelerate clinical timelines

39 seconds

Expert info

Brenda Bruker, executive director, integrated supply and delivery services, PPD clinical research business of Thermo Fisher Scientific

Bundling CDMO and CRO for speed, simplicity, and scalability in drug development

50 seconds

Expert info

Tanya Momtahen, vice president, customer asset development, PPD clinical research business of Thermo Fisher Scientific

Revolutionizing clinical trials through AI

Artificial intelligence (AI) is disrupting and transforming traditional clinical trial processes. Learn how advancements in the application of AI are breaking down barriers and building more unified workflows.

AI-driven digital transformation enhances speed and efficiency in our industry

34 seconds

Expert info

Mike Kleppinger, president, commercial, PPD clinical research business of Thermo Fisher Scientific

Using AI to reduce white space and accelerate clinical trial timelines

1 minute 42 seconds

Expert info

John Van Hoy, executive director, data science, PPD clinical research business of Thermo Fisher Scientific

AI transforming data monitoring and cleaning in clinical trials: a unified approach

1 minute 18 seconds

Expert info

John Van Hoy, executive director, data science, PPD clinical research business of Thermo Fisher Scientific

Flexible delivery models

A one-size-fits-all approach doesn’t apply to clinical development. When trials demand flexibility, FSP solutions deliver the expertise you want and the on-time delivery you need.

Flexible FSP solutions offering regulatory, pharmacovigilance, and clinical support

1 minute 4 seconds

Expert info

Heather Hutsell, director, oversight delivery lead, PPD clinical research business of Thermo Fisher Scientific

Leveraging innovation and mitigating risk

The abundance of new technologies and approaches driving the industry forward can leave drug developers overwhelmed and looking for guidance to determine the best path forward. Our experts help you cut through the noise and determine what’s right for your study and what can be left behind.

Embrace change to accelerate drug development and reduce patient treatment delays

40 seconds

Expert info

Mike Kleppinger, president, commercial, PPD clinical research business of Thermo Fisher Scientific

Engage your CRO early to mitigate risks and avoid amendments

37 seconds

Expert info

Tanya Momtahen, vice president, customer asset development, PPD clinical research business of Thermo Fisher Scientific

Using social media and machine learning to enhance patient-centered care

58 seconds

Expert info

Ariel Berger, executive director, integrated solutions RWE, PPD clinical research business of Thermo Fisher Scientific

Embrace AI and digital tools to accelerate development and improve patient care

38 seconds

Expert info

Mike Kleppinger, president, commercial, PPD clinical research business of Thermo Fisher Scientific

Maximizing ROI with RWE

With more data being produced, pharmaceutical companies have the opportunity to tap into vast amounts of knowledge to advance their most promising assets. Effective use of real-world evidence is reshaping how sponsors tell their value story.

Using real world evidence to expand indications and develop new drug assets

46 seconds

Expert info

Ariel Berger, executive director, integrated solutions RWE, PPD clinical research business of Thermo Fisher Scientific

Maximize ROI by proactively engaging with unique real world data assets early

29 seconds

Expert info

Dr. Pete Wahl, MLA, MS, SCD, vice president, global head of scientific affairs, CorEvitas